Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing RSV diagnosis by improving RSV detection in patients admitted to ED/hospitalized due to respiratory symptomsRelease Date:Quality Improvement Vaccines Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Sweden, Switzerland Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Implementing Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease USA Title Grant Type Focus Area Country Application Due Date Addressing Healthcare Disparities in the Recognition, Early Diagnosis and Treatment of Primary ImmunodeficienciesRelease Date:Education Hospital USA Knowledge Gaps in the Prevention of COVID-19 in EuropeRelease Date:Education Vaccines All Hemophilia: Improving Knowledge of Novel Hemophilia Therapies Amongst Multidisciplinary TeamsRelease Date:Education Rare Disease USA Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate CancerEducation Oncology USA Quality of Care Initiative to Improve the Treatment of Advanced or Metastatic Bladder Cancer PatientsQuality Improvement Oncology USA Educational Projects for Healthcare Professionals to Promote Cancer Patient SupportRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Latin America Needs Assessment of Prostate CancerRelease Date:Education Oncology All Menopause and Mental HealthRelease Date:Education Internal Medicine USA Efforts to Promote an Environmental Improvement for Cancer Genomic MedicineRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Understanding of Biosimilars and Shared Decision Making including Financial Burden in Cancer TreatmentRelease Date:Education Oncology Japan Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal diseaseRelease Date:Research Vaccines Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam Addressing Diagnostic Challenges for Non-Alcoholic Steatohepatitis (NASH)Release Date:Education Internal Medicine All